image
Rhythm Pharmaceuticals, Inc. RYTM
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 56.23
-5.92 %
$ 3.46 B
Market Cap
-13.02
P/E
INCOME STATEMENT
77.4 M REVENUE
227.56%
Growth Rates
1Year 227.56%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-184 M OPERATING INCOME
-2.90%
Growth Rates
1Year -2.90%
3Years -10.52%
5Years -18.65%
7Years -32.36%
10Years -24.00%
-185 M NET INCOME
-1.97%
Growth Rates
1Year -1.97%
3Years -11.29%
5Years -20.05%
7Years -32.42%
10Years -24.03%
EFFICIENCY
Earnings Waterfall Rhythm Pharmaceuticals, Inc.
image
Revenue 77.4 M
Cost Of Revenue 9.3 M
Gross Profit 68.1 M
Operating Expenses 252 M
Operating Income -184 M
Other Expenses 321 K
Net Income -185 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 77.4 23.6 3.2 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 9.3 2.1 0.6 0.7 0.8 0.4 0.2 0.1 0 0 0 0
Gross Profit 68.1 21.5 2.6 (0.7) (0.8) (0.4) (0.2) (0.1) 0 0 0 0
OPERATING INCOME
Operating Expenses 252.5 200.7 172.6 136.6 146.0 78.4 32.4 25.9 10.6 6.5 21.4 18.1
Selling, General and Administrative Expenses 117.5 92.0 68.5 46.1 36.5 28.1 9.5 6.3 3.4 1.2 3.4 2.5
Research and Development Expenses 135.0 108.6 104.1 90.5 109.5 50.3 22.9 19.6 7.1 5.3 18.0 15.7
Operating Income (184.4) (179.2) (170.1) (136.6) (146.0) (78.4) (32.4) (25.9) (10.6) (6.5) (21.4) (18.1)
PRE-TAX INCOME
Interest Income Expense 13.9 5.2 0 0 0 0 0 0 0 0 0 0
Total Other Income 0.2 (2.0) 100.4 2.6 5.3 4.4 (1.3) 33 K (0.5) 0 17 K 8 K
Pre-Tax Income (184.1) (181.1) (69.6) (134.0) (140.7) (74.1) (33.7) (25.9) (11.1) (6.5) (21.4) (18.1)
NET INCOME
Tax Provision 0.6 2.0 (1.6) (3.3) (6.1) 4.4 1.1 0 0 0 0 0
Net Income (184.7) (183.1) (68.0) (130.7) (134.6) (74.1) (33.7) (25.9) (11.1) (6.5) (21.4) (18.1)
EPS 3.2 3.51 1.37 2.96 3.7 2.39 2.54 1.55 0.66 0.64 0.43 0.36